851 related articles for article (PubMed ID: 31591683)
1. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
[TBL] [Abstract][Full Text] [Related]
2. Regulating the gut microbiota and SCFAs in the faeces of T2DM rats should be one of antidiabetic mechanisms of mogrosides in the fruits of Siraitia grosvenorii.
Zhang Y; Peng Y; Zhao L; Zhou G; Li X
J Ethnopharmacol; 2021 Jun; 274():114033. PubMed ID: 33741440
[TBL] [Abstract][Full Text] [Related]
3. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota.
Zhao L; Lou H; Peng Y; Chen S; Fan L; Li X
Diabetes Res Clin Pract; 2020 Nov; 169():108418. PubMed ID: 32891692
[TBL] [Abstract][Full Text] [Related]
5. Prebiotic effect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial.
Birkeland E; Gharagozlian S; Birkeland KI; Valeur J; Måge I; Rud I; Aas AM
Eur J Nutr; 2020 Oct; 59(7):3325-3338. PubMed ID: 32440730
[TBL] [Abstract][Full Text] [Related]
6. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
[TBL] [Abstract][Full Text] [Related]
7. Intake of total saponins and polysaccharides from Polygonatum kingianum affects the gut microbiota in diabetic rats.
Yan H; Lu J; Wang Y; Gu W; Yang X; Yu J
Phytomedicine; 2017 Mar; 26():45-54. PubMed ID: 28257664
[TBL] [Abstract][Full Text] [Related]
8. Metagenomics and Faecal Metabolomics Integrative Analysis towards the Impaired Glucose Regulation and Type 2 Diabetes in Uyghur-Related Omics.
Nuli R; Azhati J; Cai J; Kadeer A; Zhang B; Mohemaiti P
J Diabetes Res; 2019; 2019():2893041. PubMed ID: 31828159
[TBL] [Abstract][Full Text] [Related]
9. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.
Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D
Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709
[TBL] [Abstract][Full Text] [Related]
10. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.
Alvarez-Silva C; Kashani A; Hansen TH; Pinna NK; Anjana RM; Dutta A; Saxena S; Støy J; Kampmann U; Nielsen T; Jørgensen T; Gnanaprakash V; Gnanavadivel R; Sukumaran A; Rani CSS; Færch K; Radha V; Balasubramanyam M; Nair GB; Das B; Vestergaard H; Hansen T; Mande SS; Mohan V; Arumugam M; Pedersen O
Genome Med; 2021 Mar; 13(1):37. PubMed ID: 33658058
[TBL] [Abstract][Full Text] [Related]
11. Implication of the gut microbiome composition of type 2 diabetic patients from northern China.
Li Q; Chang Y; Zhang K; Chen H; Tao S; Zhang Z
Sci Rep; 2020 Mar; 10(1):5450. PubMed ID: 32214153
[TBL] [Abstract][Full Text] [Related]
12. Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS study.
Verhaar BJH; Collard D; Prodan A; Levels JHM; Zwinderman AH; Bäckhed F; Vogt L; Peters MJL; Muller M; Nieuwdorp M; van den Born BH
Eur Heart J; 2020 Nov; 41(44):4259-4267. PubMed ID: 32869053
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy.
Wang Q; Chen C; Zuo S; Cao K; Li H
J Transl Med; 2023 Jun; 21(1):395. PubMed ID: 37330571
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profiles of oligosaccharides derived from four microbial polysaccharides by faecal inocula from type 2 diabetes patients.
Xu J; Liu W; Wu J; Wang W; Wang Z; Yu X; Zhang H; Zhu L; Zhan X
Int J Food Sci Nutr; 2021 Dec; 72(8):1083-1094. PubMed ID: 33870850
[No Abstract] [Full Text] [Related]
15. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites.
Xiao S; Liu C; Chen M; Zou J; Zhang Z; Cui X; Jiang S; Shang E; Qian D; Duan J
Appl Microbiol Biotechnol; 2020 Jan; 104(1):303-317. PubMed ID: 31758238
[TBL] [Abstract][Full Text] [Related]
16. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
Brunkwall L; Orho-Melander M
Diabetologia; 2017 Jun; 60(6):943-951. PubMed ID: 28434033
[TBL] [Abstract][Full Text] [Related]
17. The change of gut microbiota-derived short-chain fatty acids in diabetic kidney disease.
Zhong C; Dai Z; Chai L; Wu L; Li J; Guo W; Zhang J; Zhang Q; Xue C; Lin H; Luo Q; Cai K
J Clin Lab Anal; 2021 Dec; 35(12):e24062. PubMed ID: 34689373
[TBL] [Abstract][Full Text] [Related]
18. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Gut Microbiome and Its Metabolites, Short-Chain Fatty Acids, in Children With Idiopathic Short Stature.
Li L; Chen L; Yang Y; Wang J; Guo L; An J; Ma X; Lu W; Xiao Y; Wang X; Dong Z
Front Endocrinol (Lausanne); 2022; 13():890200. PubMed ID: 35757432
[TBL] [Abstract][Full Text] [Related]
20. Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot study.
Gravdal K; Kirste KH; Grzelak K; Kirubakaran GT; Leissner P; Saliou A; Casèn C
BMC Endocr Disord; 2023 Aug; 23(1):179. PubMed ID: 37605183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
